Pfizer (PFE), BioNTech SE (BNTX) Say Three Vaccine Doses Neutralize Omicron Variant - DJ

(Updated - December 8, 2021 6:53 AM EST)

Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said a third dose of their vaccine neutralized Omicron in lab tests, according to Dow Jones.

The two-dose regimen was significantly less effective.

A third dose increased antibodies 25-fold compared to two doses in the variant. Two doses may prove effective in preventing severe illness.

You May Also Be Interested In

• FDA: issues early alert on Abiomed heart pump controller purge cassette issue
• FDA grants fast track status to CytomX drug for colorectal cancer
• MBX Biosciences doses first patient in Phase 3 hypoparathyroidism trial